Figure 2From: Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosisRelapse-free survival (RFS) as a function of pathologic response. Residual disease (RD) with high Ki-67 showed poorer RFS than RD with low Ki-67 and pathologic complete response (pCR) with high Ki-67.Back to article page